When it comes to mental health care, there are a variety of treatment options available. These include established treatments like talk therapy and new treatments like psilocybin therapy. While both of these treatments can be effective in helping people manage their mental health issues, they work in very different ways. This article will explore the mechanisms of action of psilocybin therapy and talk therapy, as well as their potential benefits for various mental health conditions. 

What is Psilocybin Therapy?  

Psilocybin therapy is a form of psychedelic-assisted psychotherapy that involves patients ingesting the chemical psilocybin while in the care of a therapist. The patient then goes on a psychedelic journey in this controlled setting, which typically lasts six to eight hours or until the effects of the drug have worn off. During this time, the therapist facilitates their experience by providing support and guidance throughout the session.

How Does Psilocybin Work? 

Psilocybin works by binding to serotonin receptors in the brain, which helps alter neural activity and change consciousness. Additionally, research has found that psilocybin is associated with increased neuroplasticity—the ability of neurons to form new connections—which could explain why it can lead to lasting psychological change ^[1]. Furthermore, studies have demonstrated that psilocybin can lead to reduced levels of depression and anxiety and improved mood states ^[2]. These findings suggest that psilocybin could potentially treat a range of mental health conditions. 

What is Talk Therapy?

Talk therapy is an umbrella term used to describe any psychotherapy that involves talking between a patient and therapist about psychological issues or concerns. There are many different types of talk therapies available such as cognitive-behavioral therapy (CBT), psychoanalytic therapy, interpersonal therapy, and more. Talk therapy aims to help people gain insight into their thoughts and behaviors so they can make positive changes in their lives. 

How Does Talk Therapy Work?  

Talk therapies work by helping people identify patterns or underlying causes behind their thoughts or behaviors so they can develop healthier coping strategies. For example, CBT focuses on helping people become aware of how their thoughts influence their emotions and behavior so they can learn how to challenge negative thinking patterns. Similarly, psychoanalytic therapy aims to uncover unconscious motivations behind behavior so people can gain insight into themselves and make meaningful changes in their lives. Lastly, interpersonal therapy focuses on improving communication skills within relationships so individuals can better connect with others.  

Potential Benefits for Mental Health Conditions

Both psilocybin therapy and talk therapies have been studied for potential benefits for various mental health conditions, including depression, anxiety disorders, addiction disorders, posttraumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD). Studies have shown that both treatments can lead to significant reductions in symptoms when compared to placebo treatments or no treatment at all ^{[3] [4]}. However, in the case of psilocybin, more research is needed before it can be definitively recommended as an effective treatment option for any particular condition.

Comparison of Psilocybin Therapy and Talk Therapy

Psilocybin therapy involves a patient ingesting the chemical psilocybin while in the care of a therapist. The patient goes on a psychedelic journey in a controlled, safe environment, and the therapist facilitates their experience. The session typically lasts six to eight hours, which is the full duration of the drug's effects. The general standard is that the psychedelic journey occurs a single time, with standard talk therapy often continuing after.

In contrast, talk therapies involve verbal communication between patient and therapist to explore feelings, beliefs, and behavior patterns that may be causing distress or difficulty functioning in daily life. Talk therapies can include cognitive behavioral therapy (CBT), psychodynamic psychotherapy (PPT), interpersonal psychotherapy (IPT), and dialectical behavior therapy (DBT), among others. Unlike psilocybin therapy sessions which typically last six to eight hours at most, talk therapies can be ongoing over weeks or months, depending on individual needs. 

Current State of Research

The current state of research on the use of psilocybin, a compound found in certain mushrooms, as a treatment for mental health disorders such as depression and anxiety is an active and growing field. A number of studies are currently being conducted to compare the effectiveness of psilocybin therapy used with traditional forms of talk therapy, such as cognitive behavioral therapy (CBT) and interpersonal therapy (IPT).

For example, a study published in the Journal of Psychopharmacology found that two doses of psilocybin, in conjunction with psychotherapy, resulted in sustained reductions in depression and anxiety symptoms in patients with a life-threatening cancer diagnosis ^[5].

Despite these promising results, it is important to note that more research is needed before any definitive conclusions can be drawn about the effectiveness of psilocybin compared to other forms of treatment. There is a need for larger and more controlled studies to further confirm these findings and understand the potential risks and benefits of using psilocybin as a treatment option.

Legal Status and Availability of Psilocybin

The legal status and availability of psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, vary widely across different countries and regions. In some jurisdictions, psilocybin is decriminalized or even legalized for therapeutic uses under certain conditions. For example, Oregon and the cities of Oakland and Denver have all decriminalized psilocybin. And in Austria, psilocybin mushroom cultivation is legal ^[6].

In countries where access to psilocybin is decriminalized or legal, it can still be difficult for individuals to find certified practitioners who are trained and experienced in providing psychedelic-assisted treatments. While a growing number of institutions and organizations offer training in psychedelic-assisted therapy, access to these opportunities remains limited.

However, there is hope; currently, the availability of psilocybin therapy is very limited in the United States because it is not approved by the Food and Drug Administration (FDA) for the treatment of any medical condition ^[7]. However, a "compassionate use" program does exist where FDA may allow access to psilocybin for treatment in some instances, and some "psilocybin therapy" centers have opened with the support of local state ate authorities. These centers provide therapy for certain mental health conditions under a "research" paradigm.

The current research on psilocybin therapy has shown promising results for treating mental health issues such as depression and anxiety, and it is a promising alternative treatment option. As more research continues to be conducted in this field, we can expect to gain a deeper understanding of the potential benefits and effectiveness of psilocybin therapy. 

While the availability of psilocybin therapy might vary depending on location due to different laws on psychoactive substances, there are encouraging signs that this is changing. We are seeing more and more jurisdictions changing their stance on the use of psilocybin in therapy and decriminalizing or even legalizing it.

‍